Profil
Bruce P.
Connop is an Independent Director at IBEX Technologies, Inc. since 2017.
He is also the Vice President-Preclinical Research & Development at Active Pass Pharmaceuticals, Inc. since 1999.
Previously, he worked as the VP-Non Clinical & Pharmaceutical Development at Transition Therapeutics, Inc. from 2006 to 2012.
Dr. Connop holds a doctorate degree from Queen's University.
Aktiva positioner av Bruce P. Connop
| Företag | Position | Start |
|---|---|---|
| IBEX TECHNOLOGIES | Direktör/Styrelseledamot | 2017-10-11 |
Active Pass Pharmaceuticals, Inc.
Active Pass Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for infectious diseases | Teknisk/Vetenskaplig/F&U Direktör | 1999-01-01 |
Tidigare kända positioner av Bruce P. Connop
| Företag | Position | Slut |
|---|---|---|
| TRANSITION THERAPEUTICS INC | Företagsledare/Principal | - |
Bruce P. Connops utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 4 |
|---|---|
Transition Therapeutics, Inc.
Transition Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biopharmaceutical development company that manufactures novel therapeutics for CNS, metabolic diseases and androgen deficiency indications | Commercial Services |
IBEX Technologies, Inc.
IBEX Technologies, Inc. Pharmaceuticals: OtherHealth Technology Develops and manufactures specialty enzymes, diagnostic reagents & biomedical products | Health Technology |
Queen's University
Queen's University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Active Pass Pharmaceuticals, Inc.
Active Pass Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for infectious diseases | Health Technology |
















